Wire · operational-macro
Creative Medical Technology Takes 80% Control of BioDefense in Cash-and-Stock Purchase
◆ Sectors
Health
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 25 September 2026 · Fusion42 review
Creative Medical Technology has increased its ownership stake in BioDefense to 80% by purchasing 4 million shares through a cash and stock deal, enhancing its control over BioDefense.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You should note that stakes in emergent healthtech firms like BioDefense are consolidating quickly. This deal raises the bar for control and influence, suggesting active moves for founders in healthtech fields to anticipate consolidation or seek partnerships.
◆ Coverage
1 source · 25 Sep 2026
◆ Related on Wire
◆ Topics
Healthm-aownershipstock-purchasehealthtechcorporate-control